发明授权
- 专利标题： Cyclic dinucleotide
-
申请号： US16185258申请日： 2018-11-09
-
公开(公告)号： US10980825B2公开(公告)日： 2021-04-20
- 发明人: Masato Yoshikawa , Morihisa Saitoh , Taisuke Kato , Yayoi Nakayama , Tomohiro Seki , Yasuo Nakagawa , Yusuke Tominari , Masaki Seto , Akito Shibuya , Kosuke Hidaka , Zenyu Shiokawa , Yoshihisa Nakada , Michiyo Mochizuki
- 申请人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址： JP Osaka
- 专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人： TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址： JP Osaka
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 优先权： JP2016-234553 20161201,JP2017-107216 20170530
- 主分类号： A61K31/7084
- IPC分类号： A61K31/7084 ; A61K31/7076 ; A61K47/68 ; A61P35/00 ; C07H21/00 ; C07H21/02
摘要：
The present disclosure provides a compound having a STING agonistic activity, which may be expected to be useful as an agent for the prophylaxis or treatment of STING-related diseases.
The present disclosure relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.
The present disclosure relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.
公开/授权文献
- US20210137962A9 CYCLIC DINUCLEOTIDE 公开/授权日：2021-05-13
信息查询
